0000899243-21-033275.txt : 20210817
0000899243-21-033275.hdr.sgml : 20210817
20210817172225
ACCESSION NUMBER: 0000899243-21-033275
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210816
FILED AS OF DATE: 20210817
DATE AS OF CHANGE: 20210817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wyzga Michael D
CENTRAL INDEX KEY: 0001877600
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37695
FILM NUMBER: 211184038
MAIL ADDRESS:
STREET 1: C/O YUMANITY, INC.
STREET 2: 40 GUEST STREET, SUITE 4410
CITY: BOSTON
STATE: MA
ZIP: 02135
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: YUMANITY THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001445283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 GUEST STREET
STREET 2: SUITE 4410
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-409-5300
MAIL ADDRESS:
STREET 1: 40 GUEST STREET
STREET 2: SUITE 4410
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140813
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC
DATE OF NAME CHANGE: 20080916
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-16
0
0001445283
YUMANITY THERAPEUTICS, INC.
YMTX
0001877600
Wyzga Michael D
C/O YUMANITY THERAPEUTICS, INC.
40 GUEST STREET, SUITE 4410
BOSTON
MA
02135
0
1
0
0
See Remarks
Stock Option (Right to Buy)
9.17
2021-08-16
4
A
0
65000
0.00
A
2031-08-15
Common Stock
65000
65000
D
25% of the shares subject to the option shall vest on August 16, 2022. The remaining 75% vest in equal monthly installments over the subsequent three years.
Sr. VP & Chief Financial Officer
/s/ Marie Epstein, Attorney-in-Fact
2021-08-17